ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,417.19
0.03%
Dow Jones
39,431.51
-0.21%
Gold vs US Dollar
2,339.565
0.02%
Brent Oil
83.125
-0.10%
Bitcoin
61,994.26
-1.45%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Rezolute Inc (RZLT)

  7. Rezolute Inc (RZLT) News

Rezolute (RZLT)

Rezolute Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RZLT
DateTimeSourceHeadlineSymbolCompany
23/04/202413:00GlobeNewswire Inc.Phase 2 RIZE Study Sub-Analyses to be Presented at the 2024 Pediatric Endocrine Society Annual MeetingNASDAQ:RZLTRezolute Inc
11/03/202421:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RZLTRezolute Inc
11/03/202414:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RZLTRezolute Inc
06/03/202412:30GlobeNewswire Inc.Rezolute Reports Validation of the Potential Use of RZ358 for Treatment of Non-Islet Cell Tumor Hypoglycemia (NICTH)NASDAQ:RZLTRezolute Inc
27/02/202413:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RZLTRezolute Inc
22/02/202422:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RZLTRezolute Inc
21/02/202416:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RZLTRezolute Inc
13/02/202422:00Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:RZLTRezolute Inc
13/02/202421:20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RZLTRezolute Inc
13/02/202421:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RZLTRezolute Inc
13/02/202421:05GlobeNewswire Inc.Rezolute Reports Second Quarter Fiscal 2024 Results and Provides Business UpdateNASDAQ:RZLTRezolute Inc
29/01/202422:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RZLTRezolute Inc
25/01/202417:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RZLTRezolute Inc
25/01/202417:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RZLTRezolute Inc
25/01/202417:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RZLTRezolute Inc
25/01/202417:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RZLTRezolute Inc
24/01/202413:00GlobeNewswire Inc.Rezolute Expands Leadership Team with Appointment of Daron Evans, MS, MBA, as Chief Financial OfficerNASDAQ:RZLTRezolute Inc
23/01/202413:00GlobeNewswire Inc.Rezolute Receives Innovation Passport Designation from the U.K. Innovative Licensing and Access Pathway Steering Group for RZ358 in the Treatment of Hypoglycemia Due to Congenital HyperinsulinismNASDAQ:RZLTRezolute Inc
14/12/202321:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RZLTRezolute Inc
14/12/202313:00GlobeNewswire Inc.Rezolute Initiates Phase 3 Clinical Study for RZ358 in Congenital HyperinsulinismNASDAQ:RZLTRezolute Inc
13/12/202313:00GlobeNewswire Inc.Rezolute Completes Enrollment of its Phase 2 Study in Diabetic Macular Edema (“DME”)NASDAQ:RZLTRezolute Inc
30/11/202305:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RZLTRezolute Inc
22/11/202322:16Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:RZLTRezolute Inc
22/11/202321:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RZLTRezolute Inc
17/11/202313:00GlobeNewswire Inc.Rezolute to Participate in BTIG’s 3rd Annual Ophthalmology DayNASDAQ:RZLTRezolute Inc
15/11/202314:08Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:RZLTRezolute Inc
13/11/202321:21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RZLTRezolute Inc
13/11/202321:13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RZLTRezolute Inc
13/11/202321:05GlobeNewswire Inc.Rezolute Reports First Quarter Fiscal 2024 ResultsNASDAQ:RZLTRezolute Inc
18/10/202321:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RZLTRezolute Inc
 Showing the most relevant articles for your search:NASDAQ:RZLT

Your Recent History

LSE
SOLG
Solgold
LSE
TXP
Touchstone Exploration
LSE
BIRD
Blackbird
LSE
GDR
Genedrive
LSE
ARS
Asiamet Resources
LSE
AAZ
Anglo Asian Mining
LSE
OTB
On The Beach
LSE
KEFI
Kefi Gold And Copper
LSE
VOD
Vodafone
LSE
OPG
Opg Power Ventures
LSE
PET
Petrel Resources
LSE
BOO
Boohoo
LSE
CASP
Caspian Sunrise
LSE
EZJ
Easyjet
LSE
PANR
Pantheon Resources
LSE
CURY
Currys
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved